2006 Case #7 | ||
Diagnosis: Ocular tuberculosis due to Mycobacterium tuberculosis. Concomitant Harada Syndrome. |
Discussion: The aqueous fluid was positive on PCR for M. tuberculosis. PPD was positive at 18 mm. Other tests performed on serum included a negative VDRL, negative toxoplasma IgG, negative brucella agglutinins.
Posterior uveitis, as in this patient, refers to inflammation involving the choroid, retina, or both (chorioretinitis) as well as retinal vasculitis. There may also be inflammation of the posterior vitreous. In addition to location uveitis can either be granulomatous or non-granulomatous. Granulomatous uveitis as in this patient does not refer to histological finding of granulomas but rather to aggregates of white blood cells and not uniform dispersement of inflammation throughout the lesion. Most uveitis is either idiopathic or autoimmune and non-granulomatous, though two types of autoimmune uveitis, Harada syndrome and sarcoid, can cause a granulomatous uveitis. For the infectious causes of posterior granulomatous uveitis the differential diagnosis includes: toxoplasmosis, CMV (in HIV patients), Toxocara, brucellosis, syphilis, leprosy, Bartonella henselae, Borrelia, Yersinia, histolplasmosis, and cryptococosis. We have noted in a number of our patients concomitant uveitis of infectious origin together with the exudative choroidal detachment that is diagnostic of Harada syndrome. At our tropical medicine institute in Lima, we evaluate about 30 patients per year referred from the National Opthalmology Institute for evaluation of possible infectious etiologies in patients with uveitis, and about one-third are found to be infectious. Of these about 20% are due to TB. It is not possible to culture TB from the eye, so in the past, the diagnosis has usually been made on the basis of clinical suspicion, exclusion of other infectious and non-infectious causes and in the setting of a highly reactive PPD. More recently, we have been using PCR, as in this patient. Most HIV negative patients have no other obvious manifestation of tuberculosis infection. In patients with HIV our experience is that other concomitant manifestations are more common. Several large studies suggest ocular complications in 1% of all patients with clinical tuberculosis. Our experience in a highly endemic country such as Peru suggests that this number is between 0.1 and 0.5%. The patient was started on standard 4-drug TB therapy and on prednisone. Our usual practice is to treat with high dose prednisone for 2-3 weeks before tapering. After 1 month, his vision improved in the right eye to 20/20 [Images E, G] without evidence of retinal detachment. However, the left eye developed a scar in the central macula with vision remaining at counting fingers [Images F, H].
|